342 related articles for article (PubMed ID: 8782082)
41. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
Basille M; Vaudry D; Coulouarn Y; Jegou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez B
J Comp Neurol; 2000 Oct; 425(4):495-509. PubMed ID: 10975876
[TBL] [Abstract][Full Text] [Related]
42. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes.
Grimaldi M; Cavallaro S
Eur J Neurosci; 1999 Aug; 11(8):2767-72. PubMed ID: 10457173
[TBL] [Abstract][Full Text] [Related]
43. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
[TBL] [Abstract][Full Text] [Related]
44. Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons.
Tatsuno I; Uchida D; Tanaka T; Saeki N; Hirai A; Saito Y; Moro O; Tajima M
Brain Res; 2001 Jan; 889(1-2):138-48. PubMed ID: 11166697
[TBL] [Abstract][Full Text] [Related]
45. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons.
Cavallaro S; Copani A; D'Agata V; Musco S; Petralia S; Ventra C; Stivala F; Travali S; Canonico PL
Mol Pharmacol; 1996 Jul; 50(1):60-6. PubMed ID: 8700120
[TBL] [Abstract][Full Text] [Related]
46. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
Pozo D; Delgado M; Martinez C; Gomariz RP; Guerrero JM; Calvo JR
Biochim Biophys Acta; 1997 Dec; 1359(3):250-62. PubMed ID: 9434131
[TBL] [Abstract][Full Text] [Related]
47. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
48. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
[TBL] [Abstract][Full Text] [Related]
49. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor.
Ogi K; Miyamoto Y; Masuda Y; Habata Y; Hosoya M; Ohtaki T; Masuo Y; Onda H; Fujino M
Biochem Biophys Res Commun; 1993 Nov; 196(3):1511-21. PubMed ID: 7902709
[TBL] [Abstract][Full Text] [Related]
50. Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas.
Vertongen P; Devalck C; Sariban E; De Laet MH; Martelli H; Paraf F; Hélardot P; Robberecht P
J Cell Physiol; 1996 Apr; 167(1):36-46. PubMed ID: 8698838
[TBL] [Abstract][Full Text] [Related]
51. Selective expression of vasoactive intestinal peptide (VIP)2/pituitary adenylate cyclase-activating polypeptide (PACAP)3 receptors in rabbit and guinea pig gastric and tenia coli smooth muscle cells.
Teng B; Murthy KS; Kuemmerle JF; Grider JR; Makhlouf GM
Regul Pept; 1998 Oct; 77(1-3):127-34. PubMed ID: 9809806
[TBL] [Abstract][Full Text] [Related]
52. Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors.
Juarranz MG; Bolaños O; Gutiérrez-Cañas I; Lerner EA; Robberecht P; Carmena MJ; Prieto JC; Rodríguez-Henche N
Cell Signal; 2001 Dec; 13(12):887-94. PubMed ID: 11728828
[TBL] [Abstract][Full Text] [Related]
53. Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate.
Solano RM; Carmena MJ; Busto R; Sánchez-Chapado M; Guijarro LG; Prieto JC
Cell Signal; 1999 Nov; 11(11):813-9. PubMed ID: 10617284
[TBL] [Abstract][Full Text] [Related]
54. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J.
Buscail L; Gourlet P; Cauvin A; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
FEBS Lett; 1990 Mar; 262(1):77-81. PubMed ID: 2156735
[TBL] [Abstract][Full Text] [Related]
55. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.
Inagaki N; Yoshida H; Mizuta M; Mizuno N; Fujii Y; Gonoi T; Miyazaki J; Seino S
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2679-83. PubMed ID: 8146174
[TBL] [Abstract][Full Text] [Related]
56. Expression of pituitary adenylate cyclase activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla.
Moller K; Sundler F
Regul Pept; 1996 Jul; 63(2-3):129-39. PubMed ID: 8837221
[TBL] [Abstract][Full Text] [Related]
57. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro.
Sawangjaroen K; Anderson ST; Curlewis JD
J Neuroendocrinol; 1997 Apr; 9(4):279-86. PubMed ID: 9147291
[TBL] [Abstract][Full Text] [Related]
58. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
Drahushuk K; Connell TD; Higgins D
J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
[TBL] [Abstract][Full Text] [Related]
59. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury.
Jaworski DM
Cell Tissue Res; 2000 May; 300(2):219-30. PubMed ID: 10867818
[TBL] [Abstract][Full Text] [Related]
60. Retinoic acid regulation of the VIP and PACAP autocrine ligand and receptor system in human neuroblastoma cell lines.
Waschek JA; Lelievre V; Bravo DT; Nguyen T; Muller JM
Peptides; 1997; 18(6):835-41. PubMed ID: 9285932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
